Template:Autoimmune lymphoproliferative syndrome: Difference between revisions

	Autoimmune lymphoproliferative syndrome Microchapters
Home
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Autoimmune lymphoproliferative syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Criteria
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
Chest X Ray
CT
MRI
Echocardiography or Ultrasound
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Autoimmune lymphoproliferative syndrome On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Autoimmune lymphoproliferative syndrome All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Autoimmune lymphoproliferative syndrome
CDC on Autoimmune lymphoproliferative syndrome
Autoimmune lymphoproliferative syndrome in the news
Blogs on Autoimmune lymphoproliferative syndrome
Directions to Hospitals Treating Autoimmune lymphoproliferative syndrome
Risk calculators and risk factors for Autoimmune lymphoproliferative syndrome

@@ Line 11: / Line 11: @@
 !
 [[Autoimmune lymphoproliferative syndrome|Home]]
-|-
-!
-|- bgcolor="Pink"
-!
-[[Autoimmune lymphoproliferative syndrome (patient information)|Patient Information]]
 |-
 !
@@ Line 88: / Line 82: @@
 |- bgcolor="LightSkyBlue"
 !
-[[Autoimmune lymphoproliferative syndrome criteria|Criteria]]
+[[Autoimmune lymphoproliferative syndrome criteria|Diagnostic Criteria]]
 |-
 !
@@ Line 174: / Line 168: @@
 [[Autoimmune lymphoproliferative syndrome primary prevention|Primary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"
@@ Line 180: / Line 174: @@
 [[Autoimmune lymphoproliferative syndrome secondary prevention|Secondary Prevention]]
 |-
 !
 |- bgcolor="PaleTurquoise"

Latest revision as of 17:19, 20 June 2016